Published on 7 Apr 2024 on Investing.com
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard...
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard...
NASDAQ.ALNY price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free